Effect of a high intake of conjugated linoleic acid on lipoprotein levels in healthy human subjects
- PMID: 20140250
- PMCID: PMC2815780
- DOI: 10.1371/journal.pone.0009000
Effect of a high intake of conjugated linoleic acid on lipoprotein levels in healthy human subjects
Abstract
Background: Trans fatty acids are produced either by industrial hydrogenation or by biohydrogenation in the rumens of cows and sheep. Industrial trans fatty acids lower high-density lipoprotein (HDL) cholesterol, raise low-density lipoprotein (LDL) cholesterol, and increase the risk of coronary heart disease. The effects of trans fatty acids from ruminants are less clear. We investigated the effect on blood lipids of cis-9, trans-11 conjugated linoleic acid (CLA), a trans fatty acid largely restricted to ruminant fats.
Methodology/principal findings: Sixty-one healthy women and men were sequentially fed each of three diets for three weeks, in random order, for a total of nine weeks. Diets were identical except for 7% of energy (approximately 20 g/day), which was provided either by oleic acid, by industrial trans fatty acids, or by a mixture of 80% cis-9, trans-11 and 20% trans-10, cis-12 CLA. After the oleic acid diet, mean (+/- SD) serum LDL cholesterol was 2.68+/-0.62 mmol/L compared to 3.00+/-0.66 mmol/L after industrial trans fatty acids (p<0.001), and 2.92+/-0.70 mmol/L after CLA (p<0.001). Compared to oleic acid, HDL-cholesterol was 0.05+/-0.12 mmol/L lower after industrial trans fatty acids (p = 0.001) and 0.06+/-0.10 mmol/L lower after CLA (p<0.001). The total-to-HDL cholesterol ratio was 11.6% higher after industrial trans fatty acids (p<0.001) and 10.0% higher after CLA (p<0.001) relative to the oleic acid diet.
Conclusions/significance: High intakes of an 80:20 mixture of cis-9, trans-11 and trans-10, cis-12 CLA raise the total to HDL cholesterol ratio in healthy volunteers. The effect of CLA may be somewhat less than that of industrial trans fatty acids.
Trial registration: ClinicalTrials.gov NCT00529828.
Conflict of interest statement
Figures

References
-
- Ascherio A, Hennekens CH, Buring JE, Master C, Stampfer MJ, et al. Trans-fatty acids intake and risk of myocardial infarction. Circulation. 1994;89:94–101. - PubMed
-
- Willett WC, Stampfer MJ, Manson JE, Colditz GA, Speizer FE, et al. Intake of trans fatty acids and risk of coronary heart disease among women. Lancet. 1993;341:581–585. - PubMed
-
- Pietinen P, Ascherio A, Korhonen P, Hartman AM, Willett WC, et al. Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am J Epidemiol. 1997;145:876–887. - PubMed
-
- Oomen CM, Ocke MC, Feskens EJ, van Erp-Baart MA, Kok FJ, et al. Association between trans fatty acid intake and 10-year risk of coronary heart disease in the Zutphen Elderly Study: a prospective population-based study. Lancet. 2001;357:746–751. - PubMed
-
- Mozaffarian D, Katan MB, Ascherio A, Stampfer MJ, Willett WC. Trans fatty acids and cardiovascular disease. N Engl J Med. 2006;354:1601–1613. - PubMed
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical